Stockreport

How New ORIC-944 Trial Results and Earnings Update Will Impact ORIC Pharmaceuticals (ORIC) Investors [Yahoo! Finance]

Oric Pharmaceuticals, Inc.  (ORIC) 
PDF Earlier this month, ORIC Pharmaceuticals announced new efficacy and safety results from its Phase 1b trial of ORIC-944 in combination with AR inhibitors for patients wit [Read more]